Insurance Type and Quality of End-of-Life Care in Adults < 65 Years with Hematologic Malignancies.
Medicaid coverage appears linked to better end-of-life care quality for younger adults with blood cancers compared to commercial insurance.
INTRODUCTION: Adults with hematologic malignancies are at risk of low-quality end-of-life (EOL) care, with evidence suggesting patients <65 years are especially at high risk. These data suggest potentially higher quality EOL care with Medicaid compared to commercial insurance.
What the study was
- Study design
- Cohort study
- Population
- patients
- Sample size
- 2669
- Category
- Other
- Maturity
- Exploratory
- Journal
- Journal of pain and symptom management
Why it surfaced
Score 6/10 [PROMISING_PRELIMINARY]: Cohort study (Journal Article) matched 'Hematologic malignancies (AML, MDS, CLL,'. Components — novelty:1/3, relevance:2/3, design:1/2, population:2/2. Confidence: high. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.